tradingkey.logo

Bio Rad Laboratories Inc

BIO
View Detailed Chart
301.500USD
+1.960+0.65%
Close 02/06, 16:00ETQuotes delayed by 15 min
8.13BMarket Cap
LossP/E TTM

Bio Rad Laboratories Inc

301.500
+1.960+0.65%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.65%

5 Days

+2.66%

1 Month

-7.37%

6 Months

+14.07%

Year to Date

-0.49%

1 Year

-12.71%

View Detailed Chart

Key Insights

Bio Rad Laboratories Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 26 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 355.00.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bio Rad Laboratories Inc's Score

Industry at a Glance

Industry Ranking
26 / 205
Overall Ranking
108 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Bio Rad Laboratories Inc Highlights

StrengthsRisks
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Fairly Valued
The company’s latest PE is -12.56, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.58M shares, decreasing 0.02% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 151.00 shares of this stock.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
355.000
Target Price
+18.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bio Rad Laboratories Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bio Rad Laboratories Inc Info

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Ticker SymbolBIO
CompanyBio Rad Laboratories Inc
CEOSchwartz (Norman D)
Websitehttps://www.bio-rad.com/
KeyAI